Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $248,407 - $289,335
-2,470 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$90.13 - $108.78 $246,325 - $297,295
-2,733 Reduced 52.53%
2,470 $257,000
Q1 2020

May 11, 2020

SELL
$72.92 - $121.3 $27,345 - $45,487
-375 Reduced 6.72%
5,203 $438,000
Q4 2019

Jan 29, 2020

BUY
$104.49 - $114.54 $94,041 - $103,086
900 Added 19.24%
5,578 $639,000
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $5,979 - $6,781
61 Added 1.32%
4,678 $508,000
Q2 2019

Aug 14, 2019

BUY
$84.15 - $99.38 $19,775 - $23,354
235 Added 5.36%
4,617 $450,000
Q1 2019

May 09, 2019

SELL
$82.45 - $93.79 $213,380 - $242,728
-2,588 Reduced 37.13%
4,382 $399,000
Q4 2018

Feb 08, 2019

BUY
$85.8 - $99.49 $15,873 - $18,405
185 Added 2.73%
6,970 $634,000
Q3 2018

Nov 14, 2018

BUY
$85.91 - $99.17 $32,731 - $37,783
381 Added 5.95%
6,785 $667,000
Q2 2018

Aug 10, 2018

BUY
$77.48 - $87.83 $13,326 - $15,106
172 Added 2.76%
6,404 $548,000
Q1 2018

May 16, 2018

BUY
$76.55 - $87.26 $108,318 - $123,472
1,415 Added 29.38%
6,232 $0
Q4 2017

May 21, 2018

BUY
$76.93 - $83.5 $370,571 - $402,219
4,817
4,817 $389,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Braun Bostich & Associates Inc. Portfolio

Follow Braun Bostich & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.